These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8813371)

  • 1. Inhibitory effects of diltiazem, an L-type Ca2+ channel blocker, on naloxone-increased glutamate levels in the locus coeruleus of opioid-dependent rats.
    Tokuyama S; Ho IK
    Brain Res; 1996 May; 722(1-2):212-6. PubMed ID: 8813371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats.
    Tokuyama S; Zhu H; Wakabayashi H; Feng YZ; Ho IK
    J Biomed Sci; 1998; 5(1):45-53. PubMed ID: 9570513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of diltiazem, a Ca2+ channel blocker, on naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.
    Tokuyama S; Ho IK
    Psychopharmacology (Berl); 1996 May; 125(2):135-40. PubMed ID: 8783387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca2+ channel blocker, diltiazem, prevents physical dependence and the enhancement of protein kinase C activity by opioid infusion in rats.
    Tokuyama S; Feng Y; Wakabayashi H; Ho IK
    Eur J Pharmacol; 1995 Jun; 279(1):93-8. PubMed ID: 7556388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased locus coeruleus glutamate levels are associated with naloxone-precipitated withdrawal from butorphanol in the rat.
    Feng YZ; Zhang T; Rockhold RW; Ho IK
    Neurochem Res; 1995 Jun; 20(6):745-51. PubMed ID: 7566372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precipitated kappa-opioid receptor agonist withdrawal increase glutamate in rat locus coeruleus.
    Hoshi K; Ma T; Ho IK
    Eur J Pharmacol; 1996 Oct; 314(3):301-6. PubMed ID: 8957250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids.
    Tokuyama S; Zhu H; Oh S; Ho IK; Yamamoto T
    Neurochem Int; 2001 Aug; 39(2):103-9. PubMed ID: 11408088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu- and delta-opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence.
    Feng YZ; Zhang T; Tokuyama S; Zhu H; Rockhold RW; Ho IK
    Neurochem Res; 1996 Jan; 21(1):63-71. PubMed ID: 8833225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nor-binaltorphimine precipitates withdrawal and excitatory amino acid release in the locus ceruleus of butorphanol--but not morphine-dependent rats.
    Feng Y; Rockhold RW; Ho IK
    J Pharmacol Exp Ther; 1997 Nov; 283(2):932-8. PubMed ID: 9353416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased release of excitatory amino acids in rat locus coeruleus in kappa-opioid agonist dependent rats precipitated by nor-binaltorphimine.
    Hoshi K; Ma T; Oh S; Ho IK
    Brain Res; 1997 Apr; 753(1):63-8. PubMed ID: 9125432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excitatory amino acid release in the locus coeruleus during naloxone-precipitated morphine withdrawal in adjuvant arthritic rats.
    Hoshi K; Yamamoto A; Ishizuki S; Fujihira E; Ichihara K
    Inflamm Res; 2000 Jan; 49(1):36-41. PubMed ID: 10778919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible involvement of protein kinases in physical dependence on opioids: studies using protein kinase inhibitors, H-7 and H-8.
    Tokuyama S; Feng Y; Wakabayashi H; Ho IK
    Eur J Pharmacol; 1995 Sep; 284(1-2):101-7. PubMed ID: 8549612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome.
    Tokuyama S; Wakabayashi H; Ho IK
    Eur J Pharmacol; 1996 Jan; 295(2-3):123-9. PubMed ID: 8720575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diltiazem inhibits naloxone-precipitated and spontaneous morphine withdrawal in rats.
    Kishioka S; Inoue N; Nishida S; Fukunaga Y; Yamamoto H
    Eur J Pharmacol; 1996 Nov; 316(1):7-14. PubMed ID: 8982643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain.
    Fan LW; Tanaka S; Tien LT; Ma T; Rockhold RW; Ho IK
    Brain Res Bull; 2002 Jun; 58(2):149-60. PubMed ID: 12127012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone-precipitated changes in biogenic amines and their metabolites in various brain regions of butorphanol-dependent rats.
    Tokuyama S; Wakabayashi H; Hoskins B; Ho IK
    Pharmacol Biochem Behav; 1996 Jun; 54(2):461-8. PubMed ID: 8743609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
    Sinchaisuk S; Ho IK; Rockhold RW
    Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of acute and chronic opioid withdrawal by a selective soluble guanylyl cyclase inhibitor.
    Sullivan ME; Hall SR; Milne B; Jhamandas K
    Brain Res; 2000 Mar; 859(1):45-56. PubMed ID: 10720614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat.
    Zhang T; Feng Y; Rockhold RW; Ho IK
    Life Sci; 1994; 55(2):PL25-31. PubMed ID: 7912397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noradrenaline release in rat locus coeruleus is regulated by both opioid and alpha(2) -adrenoceptors.
    Nakai T; Hayashi M; Ichihara K; Wakabayashi H; Hoshi K
    Pharmacol Res; 2002 May; 45(5):407-12. PubMed ID: 12123629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.